Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
In: Neurology, Jg. 89 (2017-09-12), Heft 11, S. 1107-1108
Online
academicJournal
Titel: |
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
|
---|---|
Autor/in / Beteiligte Person: | Havrdova, Eva ; Arnold, Douglas L. ; Cohen, Jeffrey A. ; Hartung, Hans-Peter ; Fox, Edward J. ; Giovannoni, Gavin ; Schippling, Sven ; Selmaj, Krzysztof W. ; Traboulsee, Anthony ; Compston, D. Alastair S. ; Margolin, David H. ; Thangavelu, Karthinathan ; Rodriguez, Claudio E. ; Jody, Darlene ; Hogan, Richard J. ; Xenopoulos, Panos ; Panzara, Michael A. ; Coles, Alasdair J. |
Link: | |
Zeitschrift: | Neurology, Jg. 89 (2017-09-12), Heft 11, S. 1107-1108 |
Veröffentlichung: | 2017 |
Medientyp: | academicJournal |
ISSN: | 0028-3878 (print) |
DOI: | 10.1212/WNL.0000000000004313 |
Sonstiges: |
|